RY

Rahul Yadav

Active Director Director DIN 08111180
DIN 08111180 First appointment Apr 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value •••• Premium profile

About Rahul Yadav

Data last updated:

Rahul Yadav is a Director at Iriska Pharmaceuticals Private Limited (since 2018). The company operates in Healthcare. Iriska Pharmaceuticals Private Limited reported revenue of ₹3.03 Cr (FY 2025).

DIN 08111180
Primary Designation Director
Industry Healthcare
First Appointment 16 Apr 2018
Oldest Company Age 8 yrs
Largest company Iriska Pharmaceuticals Private Limited · ₹3.03 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Apr 20182018₹3.03 Cr (FY 2025)Active

Board colleagues of Rahul Yadav

NameDINCompanyDesignation
Priyanka Sharma08111181Iriska Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Iriska Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rahul Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Yadav

Rahul Yadav currently holds 1 directorship: Iriska Pharmaceuticals Private Limited (Director, since 16 Apr 2018, revenue ₹3.03 Cr (FY 2025)).

Rahul Yadav was first appointed on 16 Apr 2018 as Director at Iriska Pharmaceuticals Private Limited.

The current boards of Rahul Yadav's companies include Priyanka Sharma (Iriska Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available